SMSPHARMA.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 12:58):

Stats
本日の出来高	30 465.00
平均出来高	1.05M
時価総額	17.87B
EPS	INR0 ( 2024-02-11 )
次の収益日	( INR0 ) 2024-05-21
Last Dividend	INR0.300 ( 2022-09-22 )
Next Dividend	INR0 ( N/A )
P/E	49.44
ATR14	INR0.834 (0.39%)

ボリューム相関

長: 0.45 (neutral)

短: -0.47 (neutral)

Signal:(64.377) Neutral

SMS Pharmaceuticals 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

SMS Pharmaceuticals 相関 - 通貨/商品

0.70
( moderate )

0.14
( neutral )

-0.69
( moderate negative )

0.28
( neutral )

0.36
( neutral )

0.77
( moderate )

SMS Pharmaceuticals 財務諸表

Annual	2022
収益:	INR5.22B
総利益:	INR1.29B (24.69 %)
EPS:	INR-0.830

FY	2022
収益:	INR5.22B
総利益:	INR1.29B (24.69 %)
EPS:	INR-0.830

FY	2022
収益:	INR5.15B
総利益:	INR1.81B (35.23 %)
EPS:	INR7.35

FY	2021
収益:	INR5.61B
総利益:	INR1.81B (32.35 %)
EPS:	INR7.39

Financial Reports:

No articles found.

SMS Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.300 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

SMS Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.32%) | Divividend Growth Potential Score: 5.42 - Stable (8.45%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.200	2007-09-21
Last Dividend	INR0.300	2022-09-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR3.20	--
Avg. Dividend % Per Year	0.12%	--
Score	2.12	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	5.42
Div. Directional Score	4.70	--

Next Divdend (Est)
(2024-09-04)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.12

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.250	0.34%
2019	INR0.250	0.36%
2020	INR0.250	0.60%
2021	INR0.300	0.25%
2022	INR0.300	0.23%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAMCOIND.NS	Dividend Junior	2023-08-02	Annually	23	0.32%
KOKUYOCMLN.NS	Dividend Junior	2023-07-20	Sporadic	16	0.16%
EQUITASBNK.NS	Dividend Junior	2023-07-27	Insufficient data to determine frequency	2	0.56%
ALKEM.NS	Dividend Junior	2023-08-09	Semi-Annually	9	0.71%
SWARAJENG.NS	Dividend Knight	2023-07-06	Annually	23	2.81%
NELCO.NS	Dividend Junior	2023-06-06	Sporadic	22	0.24%
ICIL.NS	Dividend Junior	2023-08-11	Annually	10	0.77%
CENTURYPLY.NS	Dividend Junior	2023-09-20	Annually	19	0.20%
RUPA.NS	Dividend Junior	2023-08-01	Annually	13	0.60%
LODHA.NS	Dividend Junior	2023-09-07	Insufficient data to determine frequency	2	0.06%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0588	1.500	8.82	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0768	1.500	-0.258	-0.387	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3.30	1.000	9.89	9.89	[3 - 30]
operatingCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.46	2.00	6.27	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.317	1.000	8.06	8.06	[0.2 - 0.8]
operatingProfitMarginTTM	0.128	1.000	9.45	9.45	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	46.16	1.000	5.44	0	[1 - 100]
returnOnEquityTTM	0.0768	2.50	-0.166	-0.387	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
dividendYielPercentageTTM	0.153	1.500	6.19	0	[0 - 0.4]
operatingCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.576	1.500	9.49	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.92	0	[0.1 - 0.5]
Total Score				5.42

SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.